Residual Proliferation of IT–Treated PBL in Primary MLC
| Experiment No. . | AB*/B* . | AB*/C* . | ||
|---|---|---|---|---|
| Untreated (cpm ×10−3) . | Treated (cpm ×10−3) (%) . | Untreated (cpm ×10−3) . | Treated (cpm ×10−3) (%) . | |
| 1 (pt BP) | 17.4 | 0.3 (1.7) | 13.6 | 12.2 (70.5) |
| 2 (pt ER) | 47.4 | 0.9 (1.9) | 43.6 | 51.6 (108) |
| 3 (pt GA) | 31.5 | 0.6 (1.9) | 27.8 | 30.8 (96.7) |
| 4 (donor 1) | 16.4 | 0.3 (1.8) | 25.2 | 24.1 (150) |
| 5 (donor 2) | 51.7 | 0.5 (0.9) | ND | ND |
| 6 (donor 3) | 21.3 | 0.4 (1.9) | ND | ND |
| 7 (donor 4) | 13.1 | 0.2 (1.5) | 7.2 | 19.1 (146) |
| Experiment No. . | AB*/B* . | AB*/C* . | ||
|---|---|---|---|---|
| Untreated (cpm ×10−3) . | Treated (cpm ×10−3) (%) . | Untreated (cpm ×10−3) . | Treated (cpm ×10−3) (%) . | |
| 1 (pt BP) | 17.4 | 0.3 (1.7) | 13.6 | 12.2 (70.5) |
| 2 (pt ER) | 47.4 | 0.9 (1.9) | 43.6 | 51.6 (108) |
| 3 (pt GA) | 31.5 | 0.6 (1.9) | 27.8 | 30.8 (96.7) |
| 4 (donor 1) | 16.4 | 0.3 (1.8) | 25.2 | 24.1 (150) |
| 5 (donor 2) | 51.7 | 0.5 (0.9) | ND | ND |
| 6 (donor 3) | 21.3 | 0.4 (1.9) | ND | ND |
| 7 (donor 4) | 13.1 | 0.2 (1.5) | 7.2 | 19.1 (146) |
Data reported represent the mean of duplicate cultures for each independent experiment. Standard deviation was less than 10% of mean values.